Evaluating therapy for patients with minor strokes and large vessel occlusion
Official title: Therapy Evaluation in Patients With Minor Stroke and Large Vessel Occlusion: A Prospective Multicenter Registry Study
Run by Sir Run Run Shaw Hospital · NCT06633809 · Data updated 2026-11-12
This study is testing different treatment options for patients with minor strokes caused by blocked large blood vessels to see which ones help them recover better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Sir Run Run Shaw Hospital Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Status | Recruiting |
| Started | November 22, 2021 |
| Main results expected | December 31, 2026 |
| Study ends | March 1, 2027 |
| Registry record updated | October 9, 2024 |
| Trial ID | NCT06633809 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who have experienced an acute ischemic stroke with a low NIHSS score and proximal intracranial artery occlusion.
✕Probably not a fit
Patients with signs of intracranial hemorrhage, seizures at stroke onset, or significant comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter registry study focuses on acute ischemic stroke patients who present with low NIHSS scores and large vessel occlusion. The study aims to gather data on therapy strategies and follow up on these patients to evaluate their outcomes. It seeks to identify predictors of neurological deterioration and determine the most effective treatment approaches for this specific patient population. By analyzing the results, the study hopes to improve prognostic predictions and therapy evaluations for patients with minor strokes and large vessel occlusions.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for patients with minor strokes, potentially enhancing their recovery and outcomes.
How similar studies have gone: While there is limited data on this specific approach, similar studies have indicated the importance of tailored therapy strategies for minor stroke patients with large vessel occlusion.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged 18 years or older 2. Acute ischemic stroke patients of NIHSS 0-5 with 24 hours after onset 3. Proximal intracranial artery occlusion on NCCT/CTA or MRI/MRA showing occlusion of the intracranial ICA, M1, or proximal M2 vessel 4. Baseline ASPECTS ≥6 or infarct Core Volume of \< 70 on NCCT/DWI/CTP 5. Pre-mRS≤1 Exclusion Criteria: 1. Any sign of intracranial hemorrhage on baseline CT/MR; 2. Seizures at stroke onset 3. Baseline blood glucose of \<2.78 mmol or \>22.20 mmol, or platelet count \< 100,000/uL or serum creatinine levels \> 3.0 mg/dL 4. Participation in any investigational study in the previous 30 days
Where it's running
-
Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, China Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating the impact of artery calcification on stroke treatment outcomes
This study is trying to see if the amount of calcium in the arteries affects how well stroke patients do after a specific treatment for blocked blood vessels.
-
Heart assessment to check repeat-stroke risk in people with atrial fibrillation
This project will test whether detailed heart examinations can find which people with atrial fibrillation who just had an ischemic stroke are at high risk of having another stroke.
-
Video call assessment for suspected stroke
This study tests if using video calls between neurologists and emergency responders can help quickly and accurately assess patients who might be having a stroke.
-
Monitoring brain-derived tau levels in acute ischemic stroke patients
This study is testing how brain-derived tau levels change in stroke patients over 48 hours to see if it can help understand their condition and improve treatment decisions.
-
Intra-arterial clot-dissolving treatment for medium-vessel ischemic stroke
The team will test whether giving tenecteplase directly into the artery helps adults with acute ischemic stroke caused by medium-vessel blockage or severe narrowing.
-
Endovascular treatment for stroke beyond 24 hours
This study is testing whether a specific stroke treatment can help people who have had a stroke more than 24 hours ago feel better and regain independence compared to just receiving standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.